Compare

Poet Technologies/$POET

1D1W1M3M6MYTD1Y5YMAX

About Poet Technologies

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
Ticker
$POET
Sector
Semiconductors
Primary listing
NASDAQ
Employees
80
Headquarters
Toronto, Canada

POET Metrics

BasicAdvanced
$844M
-
-$0.58
0.84
-

What the Analysts think about POET

Analyst ratings (Buy, Hold, Sell) for Poet Technologies stock.
Analyst projections of the future price of Poet Technologies stock.

Bulls say / Bears say

POET’s Lumilens agreement includes an initial US$50 million purchase order, with potential cumulative purchases of more than US$500 million over five years. If it converts into qualified, repeat shipments, it could give the company a meaningful commercial foothold in AI data-centre optics. (POET Technologies)
Revenue rose 112% year on year to US$570,000 in the second quarter, marking POET’s sixth consecutive quarter of sequential growth. The net loss also narrowed from the previous quarter, offering early evidence of progress from development towards sales. (POET Technologies)
POET ended June with US$796 million in cash and short-term investments after its May financing. That gives it substantial funds to build manufacturing capacity and pursue its planned production ramp without an immediate need to raise more capital. (POET Technologies)
Despite the growth, second-quarter revenue was only US$570,000, while operating cash outflow was US$12.2 million. The company remains far from showing that product sales can cover its costs. (POET Technologies)
The Lumilens order is not yet equivalent to recognised revenue: POET says fulfilment depends on successful product development, customer qualification and scaling manufacturing. Delays or failure at any of these steps could defer or reduce the expected sales. (StockTitan)
The US$400 million financing included about 19 million new shares and warrants for a further 19 million shares. This strengthens the balance sheet, but the new securities dilute existing holders and leave a potential share-supply overhang. (POET Technologies)
Data summarised monthly by Lightyear AI. Last updated on 24 Oct 2026.

POET Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

POET Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.